Overview
David Scott practices practicing medicine in Vancouver, Canada.
Mr. Scott is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Diffuse Large B-Cell Lymphoma (DLBCL), B-Cell Lymphoma, Non-Hodgkin Lymphoma, Hodgkin Lymphoma, and Bone Marrow Transplant.
He is actively involved in clinical research, co-authoring 239 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about David W. Scott
Is David W. Scott a top-rated expert for Diffuse Large B-Cell Lymphoma (DLBCL)?
MediFind is an objective health platform that identifies experts based on real-world data. David W. Scott is classified as an Elite expert for Diffuse Large B-Cell Lymphoma (DLBCL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does David W. Scott participate in research or clinical trials?
Yes. David W. Scott has published 238 articles and abstracts on conditions like Diffuse Large B-Cell Lymphoma (DLBCL). You can view a list of David W. Scott's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- B-Cell LymphomaMr. Scott isElite. Learn about B-Cell Lymphoma.
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Non-Hodgkin LymphomaMr. Scott isElite. Learn about Non-Hodgkin Lymphoma.
- Distinguished
- Burkitt LymphomaMr. Scott isDistinguished. Learn about Burkitt Lymphoma.
- Classical Hodgkin LymphomaMr. Scott isDistinguished. Learn about Classical Hodgkin Lymphoma.
- Follicular LymphomaMr. Scott isDistinguished. Learn about Follicular Lymphoma.
- Hodgkin LymphomaMr. Scott isDistinguished. Learn about Hodgkin Lymphoma.
- Mantle Cell Lymphoma (MCL)Mr. Scott isDistinguished. Learn about Mantle Cell Lymphoma (MCL).
- Mediastinal TumorMr. Scott isDistinguished. Learn about Mediastinal Tumor.
- Advanced
- Large-Cell Immunoblastic Lymphoma
- T-Cell LymphomaMr. Scott isAdvanced. Learn about T-Cell Lymphoma.
- Experienced
- Anal CancerMr. Scott isExperienced. Learn about Anal Cancer.
- Anaplastic Large Cell LymphomaMr. Scott isExperienced. Learn about Anaplastic Large Cell Lymphoma.
- Bone Marrow TransplantMr. Scott isExperienced. Learn about Bone Marrow Transplant.
- Chronic B-Cell Leukemia (CBCL)Mr. Scott isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Mr. Scott isExperienced. Learn about Chronic Lymphocytic Leukemia (CLL).
- Febrile NeutropeniaMr. Scott isExperienced. Learn about Febrile Neutropenia.
- LeukemiaMr. Scott isExperienced. Learn about Leukemia.
- MononucleosisMr. Scott isExperienced. Learn about Mononucleosis.
- Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
- Peripheral T-Cell LymphomaMr. Scott isExperienced. Learn about Peripheral T-Cell Lymphoma.
- RhabdomyosarcomaMr. Scott isExperienced. Learn about Rhabdomyosarcoma.
- Small Lymphocytic Lymphoma (SLL)Mr. Scott isExperienced. Learn about Small Lymphocytic Lymphoma (SLL).
- Testicular CancerMr. Scott isExperienced. Learn about Testicular Cancer.